These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32187859)

  • 1. Investigating association of perineural invasion on prostate biopsy with Gleason score upgrading at prostatectomy: A multi-institutional analysis.
    Barsky AR; Kraus RD; Carmona R; Santos PMG; Li C; Schwartz LE; Ballas LK; Vapiwala N
    Cancer Med; 2020 May; 9(10):3383-3389. PubMed ID: 32187859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma.
    Rubin MA; Bassily N; Sanda M; Montie J; Strawderman MS; Wojno K
    Am J Surg Pathol; 2000 Feb; 24(2):183-9. PubMed ID: 10680885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy.
    DeLancey JO; Wood DP; He C; Montgomery JS; Weizer AZ; Miller DC; Jacobs BL; Montie JE; Hollenbeck BK; Skolarus TA
    Urology; 2013 Feb; 81(2):354-7. PubMed ID: 23374801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern Patients.
    Caster JM; Falchook AD; Hendrix LH; Chen RC
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):244-51. PubMed ID: 25841621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perineural invasion in prostate needle biopsy: Prognostic value on radical prostatectomy and active surveillance.
    Ramos N; Macedo A; Rosa J; Carvalho M
    Arch Ital Urol Androl; 2020 Dec; 92(4):. PubMed ID: 33348961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histopathological parameters in transrectal ultrasound-guided biopsies associated with tumor upgrading after radical prostatectomy: A comparative analysis of risk groups.
    Ozkaya M; Simsekoglu MF; Kalender G; Sahin KC; Gurses I
    Prostate; 2024 Sep; 84(12):1146-1156. PubMed ID: 38798171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.
    Ellis CL; Partin AW; Han M; Epstein JI
    J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perineural invasion on biopsy is associated with upstaging at radical prostatectomy in Gleason score 3 + 4 = 7 prostate cancer.
    Flood TA; Schieda N; Keefe DT; Morash C; Bateman J; Mai KT; Belanger EC; Robertson SJ; Breau RH
    Pathol Int; 2016 Nov; 66(11):629-632. PubMed ID: 27709739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perineural invasion on prostate biopsy does not predict adverse pathological outcome.
    Elharram M; Margel D; Finelli A; Trachtenberg J; Evans A; van der Kwast TH; Sweet JM; Fleshner N
    Can J Urol; 2012 Dec; 19(6):6567-72. PubMed ID: 23228294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
    Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
    BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of perineural invasion in patients who underwent radical prostatectomy for localized prostate cancer.
    Dell'Atti L
    J BUON; 2016; 21(5):1219-1223. PubMed ID: 27837626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
    Egan AJ; Bostwick DG
    Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perineural invasion on prostate needle biopsy: an independent predictor of final pathologic stage.
    de la Taille A; Katz A; Bagiella E; Olsson CA; O'Toole KM; Rubin MA
    Urology; 1999 Dec; 54(6):1039-43. PubMed ID: 10604705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perineural invasion status, Gleason score and number of positive cores in biopsy pathology are predictors of positive surgical margin following laparoscopic radical prostatectomy.
    Yang R; Cao K; Han T; Zhang YF; Zhang GT; Xu LF; Lian HB; Li XG; Guo HQ
    Asian J Androl; 2017; 19(4):468-472. PubMed ID: 27004537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathological upgrading after radical prostatectomy in low-risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?
    Verep S; Erdem S; Ozluk Y; Kilicaslan I; Sanli O; Ozcan F
    Prostate; 2019 Sep; 79(13):1523-1529. PubMed ID: 31269285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer.
    Beard CJ; Chen MH; Cote K; Loffredo M; Renshaw AA; Hurwitz M; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):19-24. PubMed ID: 14697416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer.
    Truong M; Slezak JA; Lin CP; Iremashvili V; Sado M; Razmaria AA; Leverson G; Soloway MS; Eggener SE; Abel EJ; Downs TM; Jarrard DF
    Cancer; 2013 Nov; 119(22):3992-4002. PubMed ID: 24006289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer.
    Yang DD; Mahal BA; Muralidhar V; Nezolosky MD; Vastola ME; Labe SA; Boldbaatar N; King MT; Martin NE; Orio PF; Beard CJ; Hoffman KE; Trinh QD; Spratt DE; Feng FY; Nguyen PL
    Eur Urol Focus; 2019 Jan; 5(1):69-76. PubMed ID: 28753811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing patient selection for prostate monotherapy.
    Lee AK; Schultz D; Renshaw AA; Richie JP; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):673-7. PubMed ID: 11172948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen 10-20 ng/mL: A predictor of degree of upgrading to ≥8 among patients with biopsy Gleason score 6.
    Santok GD; Abdel Raheem A; Kim LH; Chang K; Lum TG; Chung BH; Choi YD; Rha KH
    Investig Clin Urol; 2017 Mar; 58(2):90-97. PubMed ID: 28261677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.